BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36609929)

  • 1. Seven centimeters as an optimal cutoff value for prognosis stratification in large monofocal hepatocellular carcinoma.
    Yen YH; Li WF; Kee KM; Wang CC; Cheng YF; Lu SN; Hung CH; Liu YW; Hu TH
    Langenbecks Arch Surg; 2023 Jan; 408(1):12. PubMed ID: 36609929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monofocal hepatocellular carcinoma: How much does size matter?
    Pelizzaro F; Penzo B; Peserico G; Imondi A; Sartori A; Vitale A; Cillo U; Giannini EG; Forgione A; Ludovico Rapaccini G; Di Marco M; Caturelli E; Zoli M; Sacco R; Cabibbo G; Marra F; Mega A; Morisco F; Gasbarrini A; Svegliati-Baroni G; Giuseppe Foschi F; Olivani A; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Farinati F;
    Liver Int; 2021 Feb; 41(2):396-407. PubMed ID: 33155401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
    Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
    Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
    Langenbecks Arch Surg; 2023 May; 408(1):169. PubMed ID: 37121930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
    Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
    Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
    Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
    Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
    Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
    Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
    Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
    Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
    Wang YY; Dong K; Wang K; Sun Y; Xing BC
    Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
    Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
    Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Wang X; Wang Z; Wu L
    BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
    Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
    World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number.
    Hu XS; Yang HY; Leng C; Zhang ZW
    World J Gastroenterol; 2022 Nov; 28(44):6271-6281. PubMed ID: 36504552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.